GIP Receptor Antagonist, SKL-14959 Indicated Alteration of the Lipids Metabolism to Catabolism by the Inhibition of Plasma LPL Activity, Resulting in the Suppression of Weight Gain on Diets-Induced Obesity Mice

References

• WHO. World Health Organization: obesity and overweight. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Accessed 2 20, 2021.
   Google Scholar
• CDC. Centers for disease control and prevention: healthy weight. the health effects of overweight and obesity. Available from: https://www.cdc.gov/healthyweight/effects/index.html. Accessed 2 20, 2021.
   Google Scholar
• Dupre J , Ross SA , Watson D , Brown JC . Stimulation of insulin secretion by gastric inhibitory polypeptide in man. J Clin Endocrinol Metab . 1973;37(5):826. doi:10.1210/jcem-37-5-826 4749457
   PubMed Web of Science ®Google Scholar
• Pederson RA , Schubert HE , Brown JC . Gastric inhibitory polypeptide. Its physiologic release and insulinotropic action in the dog. Diabetes . 1975;24(12):1050–1056. doi:10.2337/diab.24.12.1050 1193309
   PubMed Web of Science ®Google Scholar
• Beck B , Max JP . Hypersensitivity of adipose tissue to gastric inhibitory polypeptide action in the obese zucker rat. Cell Mol Biol . 1987;33(5):555–562.3319175
   PubMed Web of Science ®Google Scholar
• Oben J , Morgan L , Fletcher J , Marks. V . Effect of the entero-pancreatic hormones, gastric inhibitory polypeptide and glucagon-like polypeptide-1(7-36) amide, on fatty acid synthesis in explants of rat adipose tissue. J Endocrinol . 1991;130(2):267–272. doi:10.1677/joe.0.1300267 1919397
   PubMed Web of Science ®Google Scholar
• Eckel RH , Fujimoto WY , Brunzell JD . Gastric inhibitory polypeptide enhanced lipoprotein lipase activity in cultured preadipocyte. Diabetes . 1979;28(12):1141–1142. doi:10.2337/diab.28.12.1141 510813
   PubMed Web of Science ®Google Scholar
• Knapper JME , Puddicombe SM , Morgan LM , Fletcher JM . Investigations into the actions of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (7-36) amide on lipoprotein lipase activity in explants of rat adipose tissue. J Nutr . 1995;25:183–188.
   Google Scholar
• Wasada T , McCorkle K , Harris V , Koichi K , Howard B , Unger RH . Effect of gastric inhibitory polypeptide on plasma levels of chylomicron triglycerides in dog. J Clin Invest . 1981;68(4):1106–1107. doi:10.1172/JCI110335 7287903
   PubMed Web of Science ®Google Scholar
• Ebert R , Nauck M , Creutzfeldt W . Effect of exogenous or endogenous gastric inhibitory polypeptide (GIP) on plasma triglyceride responses in rats. Horm Metab Res . 1991;23(11):517–521. doi:10.1055/s-2007-1003745 1816061
   PubMed Web of Science ®Google Scholar
• Norris GAMAR , Morgan F , Morgan L , Hampton S , Wright J , Marks V . Elevated post-prandial gastric inhibitory polypeptide concentrations in hypertriglyceridemic subjects. Clin Sci . 1997;93(4):343–347. doi:10.1042/cs0930343
   Web of Science ®Google Scholar
• Tornvall P , Olivecrona G , Karpe F , Hamsten A , Olivecrona T . Lipoprotein lipase mass and activity in plasma and their increase after heparin are separate parameter with different relations to plasma lipoproteins. Arter Thromb Vasc Biol . 1995;15(8):1086–1093. doi:10.1161/01.ATV.15.8.1086
   Web of Science ®Google Scholar
• Robert EH , Goldberg IJ , Steiner L , Yost TJ , Paternti JR . Relationship to postheparin lipolytic activity and evidence for metabolic regulation. Diabetes . 1988;37(5):610–615. doi:10.2337/diab.37.5.610 3360217
   PubMed Web of Science ®Google Scholar
• Peterson J , Bengtsson-Olivecrona G , Olivecrona T . Mouse preheparin plasma contains high levels of hepatic lipase with low affinity for heparin. Biochem Biophys Acta . 1986;878(1):65–70. doi:10.1016/0005-2760(86)90344-9 3730415
   PubMed Web of Science ®Google Scholar
• Miyawaki K , Yamada Y , Ban N , et al. Inhibition of gastric inhibitory polypeptide signaling prevent obesity. Nat Med . 2002;8(7):738–742. doi:10.1038/nm727 12068290
   PubMed Web of Science ®Google Scholar
• Gault VA , McClean PL , Cassidy RS , Irwin N , Flatt PR . Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets. Diabetologia . 2002;50(8):1752–1762. doi:10.1007/s00125-007-0710-4
   Web of Science ®Google Scholar
• Irwin N , McClean PL , Fpm O , et al. Early administration of the Glucose-dependent insulinotropic polypeptide receptor antagonist (Pro3) GIP prevents the development of diabetes and related metabolic abnormalities associated with genetically inherited obesity in ob/ob mice. Diabetologia . 2007;50(7):1532–1540. doi:10.1007/s00125-007-0692-2 17486314
   PubMed Web of Science ®Google Scholar
• Baldassano S , Gasbjerg LS , Kizikaya HS , et al. Increased body weight and fat mass after subchronic GIP receptor antagonist, but not GLP-2 receptor antagonist, administration in rat. Front Endocrinol (Lausanne) . 2019;10:492. doi:10.3389/fendo.2019.00492 31447774
   PubMed Web of Science ®Google Scholar
• Nakamura T , Tanimoto H , Mizuno Y , et al. Biological and functional characteristics of a novel low-molecular-weight antagonist of glucose-dependent insulinotropic polypeptide receptor, SKL-14959, in vitro and in vivo. Diabetes Obes Metab . 2012;14(6):511–517. doi:10.1111/j.1463-1326.2011.01555.x 22192426
   PubMed Web of Science ®Google Scholar
• Nakamura T , Tanimoto H , Mizuno Y , et al. Gastric inhibitory polypeptide receptor antagonist, SKL-14959, suppressed body weight gain on diet-induced obesity mice. Obes Sci Pract . 2018;4(2):194–203. doi:10.1002/ops4.164.29670757
   PubMed Web of Science ®Google Scholar
• Han L-K , Takaku T , Li. J , Kimura Y , Okuda H . Anti-obesity action of oolong tea. Int J Obes . 1999;23(1):98–105. doi:10.1038/sj.ijo.0800766
   PubMed Web of Science ®Google Scholar
• Folch BJ , Lees M , Sloanestanley GH . A simple method for the isolated and purification of total lipids from animal tissue. J Biol Chem . 1956;497–509.
   Web of Science ®Google Scholar
• Krauss RM , Windmueller HG , Levy RI , Fredrickson DS . Selective measurement of two different triglyceride lipase activities in rat postheparin plasm. J Lipid Res . 1973;14(3):286–295. doi:10.1016/S0022-2275(20)36886-3 9704072
   PubMed Web of Science ®Google Scholar
• Gerhild Z , Lutz H , Fritz S , et al. Inversion of lipase stereospecificity for fluorogenic alkyldiacyl glycerols effect of substrate solubilization. Eur J Biochem . 1995;231(1):50–55. doi:10.1111/j.1432-1033.1995.0050f.x 7628484
   PubMedGoogle Scholar
• Cynthia C , Daniel LS . Hepatic lipase, high density lipoproteins, and hypertriglyceridemia. Am J Pathol . 2011;178(4):1429–1433. doi:10.1016/j.ajpath.2010.12.050 21406176
   PubMed Web of Science ®Google Scholar
• Kim SJ , Nian C , Mclntosh CHS . Activation of lipoprotein lipase by glucose-dependent insulinotropic polypeptide in adipocytes. J Biol Chem . 2007;282(12):8557–8567. doi:10.1074/jbc.M609088200 17244606
   PubMed Web of Science ®Google Scholar
• Eckel RH , Underhill LH , Eckel RH . Lipoprotein lipase: a multifunctional enzyme relevant to common metabolic diseases. N Engl J Med . 1989;320(16):1060–1068. doi:10.1056/NEJM198904203201607 2648155
   PubMed Web of Science ®Google Scholar
• Saltin B , Henriksson J , Nygaard E , et al. Fiber types and metabolic potentials of skeletal muscles in sedentary man and endurance runner. Ann NY Acad Sci . 1977;301(1 The Marathon):3–29. doi:10.1111/j.1749-6632.1977.tb38182.x 73362
   PubMedGoogle Scholar
• Simon E , Kim B , Morteza P . Mammalian β-oxidation. Biochem J . 1996;320(2):345–357. doi:10.1042/bj3200345 8973539
   PubMed Web of Science ®Google Scholar
• Felts PW , Crofford OB , Park CR . Effect of infused ketone bodies on glucose utilization in the dog. J Clin Invest . 1964;43(4):638–646. doi:10.1172/JCI104949 14149917
   PubMed Web of Science ®Google Scholar
• Mahendran Y , Vangipurapu J , Cederberg H , et al. Association of ketone body levels with hyperglycemia and type 2 diabetes in 9398 Finnish men. Diabetes . 2013;62(10):3618–3626. doi:10.2337/db12-1363 23557707
   PubMed Web of Science ®Google Scholar
• Huang BW , Chiang MT , Yao HT , Chiang W . The effect of high-fat and high fructose diets on glucose tolerance and plasma lipid and leptin levels in rats. Diabetes Obes Metab . 2004;6(2):120–126. doi:10.1111/j.1462-8902.2004.00323.x 14746577
   PubMed Web of Science ®Google Scholar
• Wang H , Knaub LA , Jensen DR , et al. Skeletal muscle-specific deletion of lipoprotein lipase enhances insulin signaling inn skeletal muscle but causes insulin resistance inn liver and other tissues. Diabetes . 2009;58(1):116–124. doi:10.2337/db07-1839 18952837
   PubMed Web of Science ®Google Scholar
• Augustus AS , Buchanan J , Park TS , et al. Loss of lipoprotein lipase-derived fatty acids leads to increased cardiac glucose metabolism and heart dysfunction. J Biol Chem . 2006;281(13):8716–8723. doi:10.1074/jbc.M509890200 16410253
   PubMed Web of Science ®Google Scholar
• Kobayashi J , Hashimoto H , Fukamachi I , et al. Lipoprotein lipase mass and activity in severe hypertriglyceridemia. Clin Chem Acta . 1993;216(1–2):113–123. doi:10.1016/0009-8981(93)90144-S
   Web of Science ®Google Scholar
• Ranganath LR , Beety JM , Wright J , Morgan LM . Nutrient regulation of post-heparin lipoprotein lipase activity in obese subjects. Horm Metab Res . 2001;33(1):57–61. doi:10.1055/s-2001-12628 11280717
   PubMed Web of Science ®Google Scholar
• Miyashita Y , Shirai K . Clinical determination of the severe of metabolic syndrome: preheparin lipoprotein lipase mass as new marker of metabolic syndrome. Curr Med Chem . 2005;3(4):377–381. doi:10.2174/156801605774322292
   Google Scholar
• Saiki A , Oyama T , Endo K , et al. Preheparin serum lipoprotein lipase mass might be a biomarker of metabolic syndrome. Diabetes Res Clin Pract . 2007;76(1):93–101. doi:10.1016/j.diabres.2006.08.004 16956692
   PubMed Web of Science ®Google Scholar
• Hanyu O , Miida T , Kosuge K , et al. Preheparin lipoprotein lipase mass is a practical marker of insulin resistance in ambulatory type 2 diabetic patients treated with oral hypoglycemic agents. Clin Chem Acta . 2007;384(1–2):118–123. doi:10.1016/j.cca.2007.06.015
   Web of Science ®Google Scholar